Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Shawn T. Wasilenko"'
Autor:
Mariam Goubran, Weiwei Wang, Stanislav Indik, Alexander Faschinger, Shawn T. Wasilenko, Jasper Bintner, Eric J. Carpenter, Guangzhi Zhang, Paulo Nuin, Georgina Macintyre, Gane K.-S. Wong, Andrew L. Mason
Publikováno v:
Viruses, Vol 14, Iss 5, p 886 (2022)
A human betaretrovirus (HBRV) has been linked with the autoimmune liver disease, primary biliary cholangitis (PBC), and various cancers, including breast cancer and lymphoma. HBRV is closely related to the mouse mammary tumor virus, and represents th
Externí odkaz:
https://doaj.org/article/711354573a6f47488b8095d672bc8faf
Publikováno v:
Viruses, Vol 5, Iss 2, Pp 423-438 (2013)
Autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) are poorly understood autoimmune liver diseases. Immunosuppression is used to treat AIH and ursodeoxycholic acid is used to slow the progression of PBC. Nevertheless, a proportion of pati
Externí odkaz:
https://doaj.org/article/9d591c9d54704a57b67893f083cf0eeb
Publikováno v:
World Journal of Gastrointestinal Surgery
BACKGROUND Gastrointestinal neurofibromas are commonly found in patients diagnosed with neurofibromatosis type 1. However, isolated gastrointestinal neurofibromas are a rare entity and only fourteen cases of isolated colorectal neurofibromas have bee
Autor:
Brendan P. Halloran, Weiwei Wang, Tracy Jordan, Eytan Wine, Deyong Song, Richard N. Fedorak, Jordan Patterson, Bo Meng, Karen Madsen, Eric J. Carpenter, Andrew Mason, Mandana Rahbari, Glenn Ford, Juan Jovel, Sandra OʼKeefe, Gane Ka-Shu Wong, Zhijian Tian, Levinus A. Dielemann, Troy Mitchell, Shawn T. Wasilenko, Yong Zhang, Salman Reza
Publikováno v:
Inflammatory Bowel Diseases
Article first published online 29 April 2015.
Inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are poorly understood disorders affecting the intestinal tract. The current model for disease suggests that genetically susc
Inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are poorly understood disorders affecting the intestinal tract. The current model for disease suggests that genetically susc
Autor:
A. Faschinger, Andrew Mason, Shawn T. Wasilenko, Stanislav Indik, Eric J. Carpenter, Gane Ka-Shu Wong, Y. Zhang, Z. Tian, Weiwei Wang
Publikováno v:
Alimentary Pharmacology & Therapeutics
Summary Background A human betaretrovirus (HBRV) has been linked with primary biliary cirrhosis (PBC) following the detection of viral particles in biliary epithelium by electron microscopy and cloning of the betaretrovirus genome from biliary epithe
Autor:
Don Graham, Aldo J. Montano-Loza, Andrew Mason, Banu Sis, Chelsea McDougall, Safwat Girgis, Min Chen, Shawn T. Wasilenko, Guangzhi Zhang, David Sharon
Publikováno v:
Liver International
Background & Aims The NOD.c3c4 mouse model develops autoimmune biliary disease characterized by spontaneous granulomatous cholangitis, antimitochondrial antibodies and liver failure. This model for primary biliary cirrhosis (PBC) has evidence of bili
Publikováno v:
Journal of the Canadian Association of Gastroenterology. 1:450-451
BACKGROUND: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease affecting bile ducts leading to cirrhosis and end-stage liver disease. Liver transplant is the only effective treatment however 6–59% of those transplanted deve
Publikováno v:
Alimentary pharmacologytherapeutics. 45(4)
SummaryBackground Autoimmune liver diseases (AILD) constitute the third most common indication for liver transplantation (LT) worldwide. Outcomes post LT are generally good but recurrent disease is frequently observed. Aims To describe the frequency
Publikováno v:
American Journal of Transplantation. 10:852-858
Primary biliary cirrhosis (PBC) reoccurs in a proportion of patients following liver transplantation (LT). The aims of our study were to evaluate the risk factors associated with PBC recurrence and determine whether recurrent disease constitutes a ne
Publikováno v:
Liver International. 30:871-877
Background/Aim: Up to one-third of patients with primary biliary cirrhosis (PBC) experience recurrent disease following liver transplantation, which is associated with earlier and more severe recurrence in patients treated with tacrolimus as compared